The new laboratory complements Evocutis' existing portfolio of skin care development services in laboratory and clinical testing and is particularly integrated with the LabSkin in vitro skin model production and testing facility, which enables customers to conduct animal-free assessments of their ingredients and products.

“The dedicated Skin Histology Laboratory allows interactive, real-time experimentation which provides customers with innovative and valuable data to support their product development,” said Dr Richard Bojar, chief scientific officer of Evocutis.

“Evocutis' on-going R&D program to develop and expand the range of LabSkin models as a platform for testing skin care products will enable the Skin Histology Laboratory to provide further services in the future".